Biocon Limited Announces Results for the Half-Year Ended September 30, 2009
Revenues rise to Rs 1,098 crores; EBITDA at Rs 236 crores; PAT at Rs 132 crores.
“Our numbers tell our compelling story. MTM losses are behind us. We have delivered strong earnings in the first half and are confident of sustaining this performance for the remainder of the year”, said Chairman and Managing Director, Biocon Group, Ms. Kiran Mazumdar-Shaw.
Performance Highlights
For Half-Year ended September 30, 2009
Biocon Group including German Subsidiary AxiCorp Total Income at Rs 1098 crores. Up 50% YoY. EBITDA at Rs 236 crores. YoY growth was 40%. PAT at Rs 132 crores. YoY growth was 230% (up 32% YoY pre-exceptionals). Operating Margin at 22%. Earnings Per Share at Rs 6.82.
Biocon Group excluding German Subsidiary AxiCorp Total Income at Rs 696 crores. Up 17% YoY. EBITDA at at Rs 213 crores. YoY growth was 31%. PAT at Rs 121 crores. Up 218% YoY (up 24% YoY pre-exceptionals). Operating Margin at 31%.
For three months ended September 30, 2009
Biocon Group including German Subsidiary AxiCorp. Total Income at Rs 592 crores. Up 29% YoY. EBITDA at Rs 125 crores. YoY growth was 41%. PAT at Rs 74 crores. YoY growth was 192% (up 47% YoY pre-exceptionals). Operating Margin at 21%. Earnings Per Share at Rs 3.84.
Biocon Group excluding German Subsidiary AxiCorp Total Income at Rs 379 crores. YoY growth was 20%. EBITDA at Rs 114 crores. YoY growth was 37%. PAT at Rs 69 crores. YoY growth was 190%. Operating Margin at 30%.